Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Venture
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Health Care Supplies

Covalon Technologies Ltd

+ Add to Watchlist

COV:CN

1.3000 CAD 0.1000 7.14%

As of 15:57:09 ET on 03/26/2015.

Snapshot for Covalon Technologies Ltd (COV)

Open: 1.4000 Day's Range: 1.3000 - 1.4800 Volume: 35,330
Previous Close: 1.4000 52wk Range: 1.0400 - 2.9800 1-Yr Rtn: -3.70%

Stock Chart for COV

No chart data available.
  • COV:CN 1.3000
  • 1D
  • 1M
  • 1Y
1.4000
Interactive COV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for COV

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPTSX -
Earnings Per Share (ttm) -0.1268
Est. EPS -
Est. PEG Ratio -
Market Cap (M CAD) 12.10
Shares Outstanding (M) 9.31
30 Day Average Volume 8,836
Price/Book (mrq) 2.2675
Price/Sale (ttm) 2.0592
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/28/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for COV

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for COV

Covalon Technologies Ltd. has developed therapeutic biomaterials for wound care and surgical applications and coatings. The Company offers covalent processes to apply hydrophilic and lubricious, durable coatins to polymeric medical devices. Covalon provides covalently cross-linked denatured collagen platforms for applications in wound care, drug delivery or cosmeceuticals delivery.

Brian E PedlarPresident/CEOValerio DitizioChief Scientific Officer
Kim CrooksVice President:Operations
More Company Profile & Key Executives for COV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil